{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T21:14:56Z","timestamp":1770758096981,"version":"3.50.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The mechanism by which circRERE (hsa_circ_0006837) modulates the malignant progression of gastric cancer was investigated to identify a novel biomarker and therapeutic target for this disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Hsa_circ_0006837 expression in GC tissues and cells was detected by RT-qPCR. Several data analysis methods were used to evaluate the significance of dysregulated hsa_circ_0006837 in GC. The patients were followed up for five years, and survival analysis was conducted using Kaplan-Meier curves. Cox regression was subsequently performed to analyze the risk factors for prognosis. The malignant behaviors of the cells were detected by the CCK-8 and Transwell assays. The relationship between hsa_circ_0006837 and miR-424-5p was assessed by conducting Spearman correlation analysis and verified by dual-luciferase reporter assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Hsa_circ_0006837 expression decreased in patients with GC, indicating a poorer patient prognosis. In GC cells, hsa_circ_0006837 overexpression suppressed malignant behaviors. Mechanistically, miR-424-5p was identified as a target of hsa_circ_0006837. The overexpression of miR-424-5p partially counteracted the suppressive effects of upregulated hsa_circ_0006837 on the malignant behaviors of GC cells. FBXO21 was identified as a downstream gene of the hsa_circ_0006837\/miR-424-5p axis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>To summarize, hsa_circ_0006837 is a biomarker for the prognosis of GC. Mechanistically, hsa_circ_0006837 overexpression can modulate the malignant behaviors of GC cells through miR-424-5p.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00449-w","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T14:49:05Z","timestamp":1747925345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hsa_circ_0006837 suppresses gastric cancer cell proliferation, migration, and invasion via the modulation of miR-424-5p"],"prefix":"10.1186","volume":"162","author":[{"given":"Yanxin","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"5","key":"449_CR1","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/annonc\/mdw027","volume":"27","author":"D Hashim","year":"2016","unstructured":"Hashim D, Boffetta P, La Vecchia C, Rota M, Bertuccio P, Malvezzi M, et al. The global decrease in cancer mortality: trends and disparities. Ann Oncol. 2016;27(5):926\u201333.","journal-title":"Ann Oncol"},{"issue":"4","key":"449_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/CCO.0000000000000636","volume":"32","author":"ED Saad","year":"2020","unstructured":"Saad ED, Buyse M. Statistical aspects in adjuvant and neoadjuvant trials for Gastrointestinal cancer in 2020: focus on time-to-event endpoints. Curr Opin Oncol. 2020;32(4):384\u201390.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"449_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3322\/caac.21657","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264\u201379.","journal-title":"CA Cancer J Clin"},{"key":"449_CR4","doi-asserted-by":"publisher","first-page":"153303382211505","DOI":"10.1177\/15330338221150555","volume":"22","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Liu N, Sun M. Research progress of immunotherapy for gastric Cancer. Technol Cancer Res Treat. 2023;22:15330338221150555.","journal-title":"Technol Cancer Res Treat"},{"key":"449_CR5","doi-asserted-by":"crossref","unstructured":"Takei S, Kawazoe A, Shitara K. The new era of immunotherapy in gastric Cancer. Cancers (Basel). 2022;14(4):1054.","DOI":"10.3390\/cancers14041054"},{"issue":"34","key":"449_CR6","doi-asserted-by":"publisher","first-page":"e34722","DOI":"10.1097\/MD.0000000000034722","volume":"102","author":"YH Luo","year":"2023","unstructured":"Luo YH, Yuan L, Lu DD, Yang YT, Yang Y, Du YH, et al. The mechanism of dehydroandrographolide inhibiting metastasis in gastric cancer based on network Pharmacology and bioinformatics. Med (Baltim). 2023;102(34):e34722.","journal-title":"Med (Baltim)"},{"issue":"11","key":"449_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675\u201391.","journal-title":"Nat Rev Genet"},{"key":"449_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-981-13-1426-1_4","volume":"1087","author":"N Eger","year":"2018","unstructured":"Eger N, Schoppe L, Schuster S, Laufs U, Boeckel JN. Circular RNA splicing. Adv Exp Med Biol. 2018;1087:41\u201352.","journal-title":"Adv Exp Med Biol"},{"key":"449_CR9","doi-asserted-by":"publisher","first-page":"1025218","DOI":"10.3389\/fimmu.2022.1025218","volume":"13","author":"Y Jin","year":"2022","unstructured":"Jin Y, Xing J, Xu K, Liu D, Zhuo Y. Exosomes in the tumor microenvironment: promoting cancer progression. Front Immunol. 2022;13:1025218.","journal-title":"Front Immunol"},{"key":"449_CR10","doi-asserted-by":"crossref","unstructured":"Zhu LP, He YJ, Hou JC, Chen X, Zhou SY, Yang SJ et al. The role of circrnas in cancers. Biosci Rep. 2017;37(5):BSR20170750.","DOI":"10.1042\/BSR20170750"},{"issue":"1","key":"449_CR11","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1097\/CAD.0000000000001195","volume":"33","author":"Y He","year":"2022","unstructured":"He Y, Zhang Z, Wang Z, Jiao Y, Kang Q, Li J. Downregulation of circ-SFMBT2 blocks the development of gastric cancer by targeting the miR-885-3p\/CHD7 pathway. Anticancer Drugs. 2022;33(1):e247\u201359.","journal-title":"Anticancer Drugs"},{"issue":"14","key":"449_CR12","doi-asserted-by":"publisher","first-page":"22936","DOI":"10.18632\/oncotarget.15288","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li J, Yu J, Liu H, Shen Z, Ye G, et al. Circular RNAs signature predicts the early recurrence of stage III gastric cancer after radical surgery. Oncotarget. 2017;8(14):22936\u201343.","journal-title":"Oncotarget"},{"issue":"1","key":"449_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12885-020-6515-2","volume":"20","author":"F Zhou","year":"2020","unstructured":"Zhou F, Wang D, Wei W, Chen H, Shi H, Zhou N, et al. Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma. BMC Cancer. 2020;20(1):40.","journal-title":"BMC Cancer"},{"issue":"11","key":"449_CR14","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1158\/1078-0432.CCR-22-3836","volume":"29","author":"N Ding","year":"2023","unstructured":"Ding N, You AB, Yang H, Hu GS, Lai CP, Liu W, et al. A Tumor-suppressive molecular Axis EP300\/circRERE\/miR-6837-3p\/MAVS activates type I IFN pathway and antitumor immunity to suppress colorectal Cancer. Clin Cancer Res. 2023;29(11):2095\u2013109.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"449_CR15","doi-asserted-by":"publisher","first-page":"6978","DOI":"10.1080\/21655979.2022.2037921","volume":"13","author":"J Su","year":"2022","unstructured":"Su J, Chen D, Ruan Y, Tian Y, Lv K, Zhou X, et al. LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-beta pathway by modulating miR-424-5p\/Smad7 axis. Bioengineered. 2022;13(3):6978\u201395.","journal-title":"Bioengineered"},{"issue":"Database issue","key":"449_CR16","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. StarBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92\u20137.","journal-title":"Nucleic Acids Res"},{"key":"449_CR17","doi-asserted-by":"crossref","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective MicroRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.","DOI":"10.7554\/eLife.05005"},{"issue":"D1","key":"449_CR18","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. MiRDB: an online database for prediction of functional MicroRNA targets. Nucleic Acids Res. 2020;48(D1):D127\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"449_CR19","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N. MiRWalk: an online resource for prediction of MicroRNA binding sites. PLoS ONE. 2018;13(10):e0206239.","journal-title":"PLoS ONE"},{"issue":"1","key":"449_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","volume":"15","author":"P Bardou","year":"2014","unstructured":"Bardou P, Mariette J, Escudie F, Djemiel C, Klopp C. Jvenn: an interactive Venn diagram viewer. BMC Bioinformatics. 2014;15(1):293.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"449_CR21","first-page":"100625","volume":"5","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov (Camb). 2024;5(3):100625.","journal-title":"Innov (Camb)"},{"issue":"3","key":"449_CR22","doi-asserted-by":"publisher","first-page":"e24842","DOI":"10.1002\/jcla.24842","volume":"37","author":"W Yuan","year":"2023","unstructured":"Yuan W, Fang R, Mao C, Chen H, Tai B, Cong H. Serum circular RNA Hsa_circ_0000702 as a novel biomarker for diagnosis of gastric cancer. J Clin Lab Anal. 2023;37(3):e24842.","journal-title":"J Clin Lab Anal"},{"issue":"7","key":"449_CR23","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.7150\/ijbs.39161","volume":"16","author":"M Mao","year":"2020","unstructured":"Mao M, Zhang A, He Y, Zhang L, Liu W, Song Y, et al. Development and validation of a novel nomogram to predict overall survival in gastric cancer with lymph node metastasis. Int J Biol Sci. 2020;16(7):1230\u20137.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"449_CR24","doi-asserted-by":"publisher","first-page":"e24369","DOI":"10.1002\/jcla.24369","volume":"36","author":"Y Shao","year":"2022","unstructured":"Shao Y, Qi C, Yan J, Lu R, Ye G, Guo J. Biological and clinical implications of Hsa_circ_0086720 in gastric cancer and its clinical application. J Clin Lab Anal. 2022;36(5):e24369.","journal-title":"J Clin Lab Anal"},{"issue":"8","key":"449_CR25","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1007\/s10620-021-07211-y","volume":"67","author":"J Yan","year":"2022","unstructured":"Yan J, Shao Y, Lu H, Ye Q, Ye G, Guo J. Hsa_circ_0001020 serves as a potential biomarker for gastric Cancer screening and prognosis. Dig Dis Sci. 2022;67(8):3753\u201362.","journal-title":"Dig Dis Sci"},{"key":"449_CR26","doi-asserted-by":"publisher","first-page":"1610446","DOI":"10.3389\/pore.2022.1610446","volume":"28","author":"P Zheng","year":"2022","unstructured":"Zheng P, Gao H, Xie X, Lu P. Plasma Exosomal Hsa_circ_0015286 as a potential diagnostic and prognostic biomarker for gastric Cancer. Pathol Oncol Res. 2022;28:1610446.","journal-title":"Pathol Oncol Res"},{"issue":"13","key":"449_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2217\/bmm-2023-0066","volume":"17","author":"J Yu","year":"2023","unstructured":"Yu J, Lu K, Huang H, Wang J, Yang Q. Feasibility evaluation of Hsa_circ_0005480 as an auxiliary diagnostic and prognostic indicator for gastric cancer. Biomark Med. 2023;17(13):585\u201395.","journal-title":"Biomark Med"},{"key":"449_CR28","doi-asserted-by":"publisher","first-page":"1236679","DOI":"10.3389\/fonc.2023.1236679","volume":"13","author":"M Han","year":"2023","unstructured":"Han M, Zhang M, Qi M, Zhou Y, Li F, Fang S. Regulatory mechanism and promising clinical application of Exosomal circular RNA in gastric cancer. Front Oncol. 2023;13:1236679.","journal-title":"Front Oncol"},{"issue":"4","key":"449_CR29","doi-asserted-by":"publisher","first-page":"110641","DOI":"10.1016\/j.ygeno.2023.110641","volume":"115","author":"D Chen","year":"2023","unstructured":"Chen D, Shi L, Zhong D, Nie Y, Yang Y, Liu D. Hsa_circ_0002019 promotes cell proliferation, migration, and invasion by regulating TNFAIP6\/NF-kappaB signaling in gastric cancer. Genomics. 2023;115(4):110641.","journal-title":"Genomics"},{"key":"449_CR30","doi-asserted-by":"crossref","unstructured":"Lin YH, Zhang BY, Chen ZS. CircRERE regulates the expression of GBX2 through miR-1299 and ZC3H13\/N(6)-methyladenosine (m(6)A) to promote growth and invasion of hepatocellular carcinoma cells. J Biosci. 2022;47:52.","DOI":"10.1007\/s12038-022-00298-z"},{"issue":"1","key":"449_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12282-017-0793-9","volume":"25","author":"HD Zhang","year":"2018","unstructured":"Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1\u20137.","journal-title":"Breast Cancer"},{"key":"449_CR32","doi-asserted-by":"publisher","first-page":"100381","DOI":"10.1016\/j.jbo.2021.100381","volume":"30","author":"W Fang","year":"2021","unstructured":"Fang W, Mu J, Yang Y, Liu L. CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p. J Bone Oncol. 2021;30:100381.","journal-title":"J Bone Oncol"},{"key":"449_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.07.119","volume":"625","author":"Y Li","year":"2022","unstructured":"Li Y, Lu X, Li W, Shi Z, Du W, Xu H, et al. The circRERE\/miR-144-3p\/TLR2\/MMP9 signaling axis in COPD pulmonary monocytes promotes the EMT of pulmonary epithelial cells. Biochem Biophys Res Commun. 2022;625:1\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"449_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12026-021-09255-8","volume":"70","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, He J, Feng C. CircCBFB is a mediator of hepatocellular carcinoma cell autophagy and proliferation through miR-424-5p\/ATG14 axis. Immunol Res. 2022;70(3):341\u201353.","journal-title":"Immunol Res"},{"issue":"1","key":"449_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41420-022-00934-5","volume":"8","author":"P Wang","year":"2022","unstructured":"Wang P, Liu T, Zhao Z, Wang Z, Liu S, Yang X. Correction: SPTBN2 regulated by miR-424-5p promotes endometrial cancer progression via CLDN4\/PI3K\/AKT axis. Cell Death Discov. 2022;8(1):210.","journal-title":"Cell Death Discov"},{"issue":"7","key":"449_CR36","doi-asserted-by":"publisher","first-page":"e24486","DOI":"10.1002\/jcla.24486","volume":"36","author":"Y Dai","year":"2022","unstructured":"Dai Y, Zhu Y, Xu H. circ_0004872 inhibits proliferation, invasion, and Glycolysis of oral squamous cell carcinoma by sponged miR-424-5p. J Clin Lab Anal. 2022;36(7):e24486.","journal-title":"J Clin Lab Anal"},{"issue":"46","key":"449_CR37","doi-asserted-by":"publisher","first-page":"75185","DOI":"10.18632\/oncotarget.12092","volume":"7","author":"S Wei","year":"2016","unstructured":"Wei S, Li Q, Li Z, Wang L, Zhang L, Xu Z. miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-beta signaling pathway. Oncotarget. 2016;7(46):75185\u201396.","journal-title":"Oncotarget"},{"key":"449_CR38","doi-asserted-by":"publisher","first-page":"1069204","DOI":"10.3389\/fphar.2022.1069204","volume":"13","author":"C Zeng","year":"2022","unstructured":"Zeng C, He R, Dai Y, Lu X, Deng L, Zhu Q, et al. Identification of TGF-beta signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer. Front Pharmacol. 2022;13:1069204.","journal-title":"Front Pharmacol"},{"issue":"1","key":"449_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41420-024-01882-y","volume":"10","author":"X Fang","year":"2024","unstructured":"Fang X, Chen D, Yang X, Cao X, Cheng Q, Liu K, et al. Cancer associated fibroblasts-derived SULF1 promotes gastric cancer metastasis and CDDP resistance through the TGFBR3-mediated TGF-beta signaling pathway. Cell Death Discov. 2024;10(1):111.","journal-title":"Cell Death Discov"},{"issue":"5","key":"449_CR40","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.7150\/jca.49674","volume":"12","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Liu X, Shen R, Gu X, Qian W. Fbxo21 regulates the epithelial-to-mesenchymal transition through ubiquitination of Nr2f2 in gastric cancer. J Cancer. 2021;12(5):1421\u201330.","journal-title":"J Cancer"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00449-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00449-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00449-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T14:49:11Z","timestamp":1747925351000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00449-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00449-w","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All enrolled persons gave informed consent. The acquisition of samples and clinical information was permitted by the Ethics Committee of Qingdao Central Hospital. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}